About Forest Laboratories
Forest Laboratories is a company based in New York (United States) founded in 1954 was acquired by Actavis in February 2014. Forest Laboratories has completed 1 acquisition, including Cerexa.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Forest Laboratories
Investments & Acquisitions by Forest Laboratories
Forest Laboratories has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cerexa.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Hospital-based anti-infective therapies for antibiotic-resistant infections are developed.
|
2005 |
Financial Statements - Forest Laboratories
Forest Laboratories Comparisons
Competitors of Forest Laboratories
Latest news on Forest Laboratories
Frequently Asked Questions about Forest Laboratories
Forest Laboratories was founded in 1954.
Forest Laboratories is headquartered in New York, United States. It is registered at New York, New York, United States.
Forest Laboratories was founded in 1954 and is headquartered in New York, United States. Operations focus on the pharmaceutical sector, where formulations are developed and marketed, particularly in central nervous system and cardiovascular therapeutic areas. A pipeline of product candidates spans various development stages and therapeutic fields. Key marketed brands include Bystolic, Daliresp, Fetzima, Linzess, Namenda, Saphris, Savella, Teflaro, Tudorza Pressair, and Viibryd.
Forest Laboratories has made 1 acquisition, including Cerexa.
Forest Laboratories has 1 investor. Key investors include Actavis.